9CO9
 
 | Local refinement of JN.1 spike/Nanosota-9 complex | Descriptor: | Nanosota-9, Spike glycoprotein | Authors: | Ye, G, Bu, F, Liu, B, Li, F. | Deposit date: | 2024-07-16 | Release date: | 2024-11-20 | Last modified: | 2024-12-11 | Method: | ELECTRON MICROSCOPY (3.44 Å) | Cite: | Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate. Plos Pathog., 20, 2024
|
|
9CO8
 
 | JN.1 spike/Nanosota-9 complex | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-9, Spike glycoprotein | Authors: | Ye, G, Bu, F, Liu, B, Li, F. | Deposit date: | 2024-07-16 | Release date: | 2024-11-20 | Last modified: | 2024-12-11 | Method: | ELECTRON MICROSCOPY (2.99 Å) | Cite: | Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate. Plos Pathog., 20, 2024
|
|
9CO6
 
 | BA.5 spike/Nanosota-9 complex | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, Nanosota-9, ... | Authors: | Ye, G, Bu, F, Liu, B, Li, F. | Deposit date: | 2024-07-16 | Release date: | 2024-11-20 | Last modified: | 2024-12-11 | Method: | ELECTRON MICROSCOPY (3.01 Å) | Cite: | Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate. Plos Pathog., 20, 2024
|
|
9CO7
 
 | Local refinement of BA.5 spike/Nanosota-9 complex | Descriptor: | Nanosota-9, Spike glycoprotein | Authors: | Ye, G, Bu, F, Liu, B, Li, F. | Deposit date: | 2024-07-16 | Release date: | 2024-11-20 | Last modified: | 2024-12-11 | Method: | ELECTRON MICROSCOPY (3.32 Å) | Cite: | Discovery of Nanosota-9 as anti-Omicron nanobody therapeutic candidate. Plos Pathog., 20, 2024
|
|